Mangalam Drugs VS Pharmaceuticals & Biotechnology 
1D
-0.07%
0.33%
1W
8.04%
4.85%
1M
-0.43%
2.78%
YTD
9.64%
-9.17%
1Y
-60.71%
-4.95%
3Y
-72.61%
22.13%
5Y
-79.41%
47.89%
10Y
-79.49%
190.73%
- Stock Absolute Returns
- India SENSEXAbsolute Returns
Price + DividendTotal Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.61%
0%
-2.61%
6 Months
24.54%
0%
24.54%
1 Year
-60.71%
0%
-60.71%
2 Years
-73.25%
0%
-73.25%
3 Years
-72.61%
0%
-72.61%
4 Years
-78.78%
0%
-78.78%
5 Years
-79.41%
0%
-79.41%
Latest dividend: 0.5 per share ex-dividend date: Dec-21-2017
Return QuartilesWhat is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers
Inconsistent Performance
Mangalam Drugs and Organics Ltd has not been a consistent performer in the last 1 year and longer periods
4
Quartile
QTD
8.15%
1
Quartile
Dec-Mar
0.54%
4
Quartile
Sep-Dec
-61.56%
4
Quartile
YTD
-61.04%
4
Quartile
2025
-76.21%
2
Quartile
2024
18.09%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry
Underperformer
Mangalam Drugs and Organics Ltd has been in the Third and Fourth Quartile in the last 1 year and longer periods
4
Quartile
QTD
8.15%
1
Quartile
Dec-Mar
0.54%
4
Quartile
Sep-Dec
-61.56%
4
Quartile
YTD
-61.04%
4
Quartile
2025
-76.21%
3
Quartile
2024
18.09%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s India SENSEXRisk Adjusted Returns v/s
Returns BetaReturns Beta
Beta has not been calculated since enough price history is not available
